The landscape of dementia analysis has developed significantly with the arrival of complex biomarkers, including amyloid PET scans, tau imaging, and blood-primarily based exams that could detect Alzheimer's pathology decades before signs and symptoms emerge. Although these technological improvements characterize extraordinary development in underst